Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia

被引:81
作者
Kussick, SJ
Fromm, JR
Rossini, A
Li, Y
Chang, A
Norwood, TH
Wood, BL
机构
[1] Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA
[2] Univ Washington, Med Ctr, Dept Med Educ & Biomed Informat, Seattle, WA 98195 USA
[3] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98195 USA
关键词
myelodysplasia; myelodysplastic syndromes; flow cytometry; antigen expression; cytogenetics; bone marrow;
D O I
10.1309/6PBP78G4FBA1FDG6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The ability of 4-color flow cytometry (FC) to help identify myelodysplastic syndromes (MDSs) was evaluated in 124 bone marrow aspirates from unselected patients with unexplained cytopenias and/or monocytosis. The morphologic features of bone marrow aspirate smears were correlated with FC and cytogenetic findings blindly, and patterns of antigen expression were compared with patterns seen in nonneoplastic and normal marrow specimens. Of 124 cases, 58 (46.7%) had definitive FC abnormalities ("flow-abnormal"), 19 cases (15.3%) had mild FC abnormalities of indeterminate significance, and 47 cases (37.9%) had essentially, normal FC. Highly significant differences were identified between the flow-abnormal group and other groups in mean myeloid blast percentages and numbers of abnormal antigens expressed, even when the analysis was limited to cases with fewer than 5% myeloid blasts. Strikingly, flow-abnormal cases constituted 50 (89%) of the 56 morphologically abnormal cases and 31 (94%) of the 33 cytogenetically abnormal cases, demonstrating the strong concordance of FC-identified antigenic abnormalities with morphologic features and cytogenetics in the evaluation of patients with unexplained cytopenias.
引用
收藏
页码:170 / 181
页数:12
相关论文
共 35 条
[1]  
[Anonymous], 2000, IMMUNOPHENOTYPING
[2]  
[Anonymous], 1997, Lab Hematol
[3]  
BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x
[4]   Loss of red cell A, B, and H antigens is frequent in myeloid malignancies [J].
Bianco, T ;
Farmer, BJ ;
Sage, RE ;
Dobrovic, A .
BLOOD, 2001, 97 (11) :3633-3639
[5]   Expression and prognostic significance of Bcl-2 family proteins in Myelodysplastic syndromes [J].
Boudard, D ;
Vasselon, C ;
Berthéas, MF ;
Jaubert, J ;
Mounier, C ;
Reynaud, J ;
Viallet, A ;
Chautard, S ;
Guyotat, D ;
Campos, L .
AMERICAN JOURNAL OF HEMATOLOGY, 2002, 70 (02) :115-125
[6]   Expression and activity of caspases 1 and 3 in myelodysplastic syndromes [J].
Boudard, D ;
Sordet, O ;
Vasselon, C ;
Revol, V ;
Berthéas, MF ;
Freyssenet, D ;
Viallet, A ;
Piselli, S ;
Guyotat, D ;
Campos, L .
LEUKEMIA, 2000, 14 (12) :2045-2051
[7]  
Chang CC, 2000, ARCH PATHOL LAB MED, V124, P1152
[8]   Peripheral blood MDS score: A new flow cytometric tool for the diagnosis of myelodysplastic syndromes [J].
Cherian, S ;
Moore, J ;
Bantly, A ;
Vergilio, JA ;
Klein, P ;
Luger, S ;
Bagg, A .
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2005, 64B (01) :9-17
[9]  
del Cañizo MC, 2003, HAEMATOLOGICA, V88, P402
[10]   BCL-2 PROTOONCOGENE EXPRESSION IN NORMAL AND NEOPLASTIC HUMAN MYELOID CELLS [J].
DELIA, D ;
AIELLO, A ;
SOLIGO, D ;
FONTANELLA, E ;
MELANI, C ;
PEZZELLA, F ;
PIEROTTI, MA ;
DELLAPORTA, G .
BLOOD, 1992, 79 (05) :1291-1298